• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biochem Biophys Res Commun . The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine d

tetano

Editor, Senior Moderator
Biochem Biophys Res Commun


. 2020 Nov 5;S0006-291X(20)32038-6.
doi: 10.1016/j.bbrc.2020.10.109. Online ahead of print.
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design


Danielle C Groves[SUP] 1 [/SUP], Sarah L Rowland-Jones[SUP] 2 [/SUP], Adrienn Angyal[SUP] 1 [/SUP]



Affiliations

Abstract

The development of the SARS-CoV-2 pandemic has prompted an extensive worldwide sequencing effort to characterise the geographical spread and molecular evolution of the virus. A point mutation in the spike protein, D614G, emerged as the virus spread from Asia into Europe and the USA, and has rapidly become the dominant form worldwide. Here we review how the D614G variant was identified and discuss recent evidence about the effect of the mutation on the characteristics of the virus, clinical outcome of infection and host immune response.

Keywords: Coronavirus; Mutation; Neutralising antibody; SARS-CoV-2; Spike.
 
Back
Top Bottom